Inventor · disambiguated record
Rashid Bux
Also filed as: BUX RASHID · BUX RASHID AHMED M
4 granted patents·12 pending applications·0 citations·filing 2012–2025
57Inventor score
Files withBIOMARK CANCER SYSTEMS INC7BIOMARK TECH INC4BIOMARK TECHNOLOGIES INC3BIOMARCK TECHNOLOGIES INC1BioMark Technologies Broadway1
Top patents by PatentIndex Score
16 records- 0172US11999990B2Method for assaying the activity of spermidine/spermine N1-acetyltransferaseBIOMARK TECH INC·Filed 2022·Granted Jun 4, 2024·0 cites·8 claims
- 0268US11441168B2Method for assaying the activity of spermidine/spermine N1-acetyltransferaseBIOMARK TECH INC·Filed 2021·Granted Sep 13, 2022·0 cites·10 claims
- 0365US2025314654A1Method of detecting lung cancerBIOMARK CANCER SYSTEMS INC·Filed 2025·Application pending·0 cites
- 0454US10175226B2Detection and quantification of acetylamantadine in urine samplesBIOMARK TECH INC·Filed 2017·Granted Jan 8, 2019·0 cites·6 claims
- 0552US2022003769A1Method Of Detecting Lung CancerBIOMARK CANCER SYSTEMS INC·Filed 2019·Application pending·0 cites
- 0649US2016041145A1Detection And Quantification Of Acetylamantadine In Urine SamplesBIOMARCK TECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 0748US2014315217A1Method For Assaying The Activity Of Spermidine/Spermine N1-AcetyltransferaseBioMark Technologies Broadway·Filed 2012·Application pending·0 cites
- 0847US2025339546A1Glioblastoma tumor growth inhibiton by sat1 knockdownBIOMARK CANCER SYSTEMS INC·Filed 2022·Application pending·0 cites
- 0947US2023251261A1Method of detecting lung cancerBIOMARK CANCER SYSTEMS INC·Filed 2023·Application pending·0 cites
- 1047US2015290160A1Spermidine/Spermine N1-Acetyltransferase Substrates As Anti-Cancer Drug CompoundsBIOMARK TECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 1142US2016017054A1Spermidine/Spermine N1 - Acetyltransferase Antibodies As Anti-Cancer Drug CompoundsBIOMARK TECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 1240US11656229B2Method of detecting lung cancerBIOMARK CANCER SYSTEMS INC·Filed 2016·Granted May 23, 2023·0 cites·8 claims
- 1340US2024142455A1Method of diagnosing early-stage non-small cell lung cancerBIOMARK CANCER SYSTEMS INC·Filed 2020·Application pending·0 cites
- 1437US2022260573A1Method of discriminating lung cancer patientsBIOMARK CANCER SYSTEMS INC·Filed 2020·Application pending·0 cites
- 1531US2014287446A1Monoclonal Antibody For AcetylamantadineBIOMARK TECHNOLOGIES INC·Filed 2012·Application pending·0 cites
- 1626US2017209272A1Method Of Detecting Cancer Based On Spermine/Spermidine N'-Acetyltransferase Gene ExpressionBIOMARK TECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rashid Bux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →